US Stock MarketDetailed Quotes
VRCA Verrica Pharmaceuticals
- 8.915
- -0.235-2.57%
Trading Jun 6 13:37 ET
378.17MMarket Cap-5036P/E (TTM)
9.350High8.850Low81.24KVolume9.240Open9.150Pre Close743.65KTurnover0.54%Turnover RatioLossP/E (Static)42.42MShares11.41052wk High247.64P/B134.19MFloat Cap2.86052wk Low--Dividend TTM15.05MShs Float23.290Historical High--Div YieldTTM5.46%Amplitude1.770Historical Low9.153Avg Price1Lot Size
About Verrica Pharmaceuticals Company
Verrica Pharmaceuticals, Inc. is a dermatology therapeutics company, which engages in identifying, developing, and commercializing pharmaceutical products for the treatment of skin diseases. Its products include Pipeline VP-102, Pipeline VP-103, and Pipeline VP-315. The company was founded by Matthew Davidson on July 3, 2013 and is headquartered in West Chester, PA.
Company Profile
SymbolVRCA
Company NameVerrica Pharmaceuticals
Listing DateJun 15, 2018
Issue Price15.00
Founded2013
CEOMr. Ted White
MarketNASDAQ
Employees100
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address44 West Gay Street,Suite 400
CityWest Chester
ProvincePennsylvania
CountryUnited States of America
Zip Code19380
Phone1-434-453-3300
Websitehttp://www.verrica.com
Company Executives
- Name
- Position
- Salary
- Ted White
- Chief Executive Officer, President and Director
- 3.50M
- Gary Goldenberg
- Chief Medical Officer
- --
- P. Terence Kohler, Jr
- Chief Financial Officer and Principal Accounting Officer
- --
- Joe Bonaccorso
- Chief Commercial Officer
- 2.10M
- Christopher G. Hayes
- Chief Legal Officer
- 2.56M
- Paul B. Manning
- Chairman of the Board
- --
- Sean Stalfort
- Director
- --
- Craig Ballaron
- Independent Director
- 119.19K
- Mark A. Prygocki, Sr
- Independent Director
- 119.19K
- Dr. Lawrence Eichenfield, M.D.
- Independent Director
- 119.19K
- Dr. Diem Nguyen, M.B.A.,PhD
- Independent Director
- 99.19K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
